Physician profile
Kyle Kaster
NPI 1558985523
$2,715.60
in general payments reported to CMS, 2019-2025
13 companies · $649 in 2025
The $649 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $29.87 · 2021: $167 · 2022: $1,052 · 2023: $291 · 2024: $527 · 2025: $649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,280 · Education: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,280.40 |
| Education | $185.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $700.84 | 2022-2024 | Aequalis Ascend Flex, Blueprint Patient Specific Instrumentation, Aequalis Perform |
| Smith+Nephew, INC. | $516.89 | 2022-2025 | Bone Anchors With Arthroscopic Delivery System, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Axogen | $306.72 | 2025 | |
| Boston Scientific Corporation | $256.09 | 2020-2025 | General - Pain Management |
| Medical Device Business Services, INC. | $185.99 | 2024 | |
| Heron Therapeutics, INC. | $130.23 | 2021-2023 | Aponvie |
| Abbvie INC. | $124.09 | 2022 | |
| Si-Bone, INC. | $118.40 | 2022 | |
| Orthofix Medical, INC. | $109.13 | 2024 | Spinal-Stim, Cervical-Stim |
| Zimmer Biomet Holdings, INC. | $98.70 | 2023 | |
| Vericel Corporation | $91.61 | 2021 | |
| Orthocell Ltd | $55.12 | 2025 | Remplir |
| Sonex Health, INC. | $21.79 | 2025 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Kaster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.